Skip to main content
. 2011 Nov 14;34(12):2491–2495. doi: 10.2337/dc11-0755

Table 1.

Baseline characteristics in the ADVANCE population by region

Asia EME Eastern Europe P
n 4,136 4,862 2,142
Age (years) 64.5 ± 5.7 67.1 ± 6.4 65.3 ± 6.9 <0.0001
Women 1,926 (46.6) 1,614 (33.2) 1,193 (55.7) <0.0001
Age diabetes first diagnosed (years) 56.1 ± 8.3 59.6 ± 8.8 57.1 ± 8.6 <0.0001
Duration of diabetes (years) 8 (3–12) 6 (3–11) 7 (3–12) <0.0001
History of macrovascular disease 1,261 (30.5) 1,558 (32.0) 771 (36.0) <0.0001
 Myocardial infarction 264 (6.4) 734 (15.1) 336 (15.7) <0.0001
 Stroke 576 (13.9) 275 (5.7) 172 (8.0) <0.0001
 Other 3,335 (80.6) 3,910 (80.4) 1,666 (77.8) 0.02
History of microvascular disease 496 (12.0) 461 (9.5) 198 (9.2) 0.44
 Macroalbuminuria 178 (4.3) 151 (3.1) 75 (3.5) 0.80
 Microalbuminuria 1,272 (31.5) 1,079 (23.6) 506 (25.0) 0.19
 Eye disease 340 (8.2) 327 (6.7) 128 (6.0) 0.08
Current smoking 561 (13.6) 627 (12.9) 362 (16.9) <0.0001
BMI (kg/m2) 25.3 ± 3.4 30.0 ± 5.3 30.6 ± 5.0 <0.0001
Waist circumference (cm) 90.1 ± 9.4 103.6 ± 12.7 103.4 ± 11.8 <0.0001
Fasting blood glucose (mmol/L) 8.55 ± 3.00 8.32 ± 2.50 8.76 ± 2.88 <0.0001
Nonstandardized HbA1c (%) 7.75 ± 1.76 7.28 ± 1.22 7.60 ± 1.73 <0.0001
Standardized HbA1c (%)* 7.72 ± 1.87 7.26 ± 1.30 7.52 ± 1.78 <0.0001
Systolic blood pressure (mmHg) 141.1 ± 21.7 146.1 ± 20.7 150.0 ± 21.7 <0.0001
Diastolic blood pressure (mmHg) 78.8 ± 10.9 80.5 ± 10.4 84.5 ± 11.1 <0.0001
Serum LDL cholesterol (mmol/L) 3.18 ± 1.01 2.90 ± 1.00 3.50 ± 1.05 <0.0001
Serum HDL cholesterol (mmol/L) 1.29 ± 0.37 1.22 ± 0.34 1.26 ± 0.33 <0.0001
Serum triglycerides (mmol/L) 1.60 (1.10–2.30) 1.62 (1.20–2.30) 1.77 (1.27–2.50) <0.0001
Serum creatinine (μmol/L) 80 (66–96) 86 (74–100) 85 (74–98) <0.0001
Urinary albumin-to-creatinine ratio 18.0 (8.8–49.0) 13.3 (6.2–32.7) 12.6 (5.3–34.9) <0.0001

Data are means ± SD, n (%), or quartile 2 (quartile 1–quartile 3) unless otherwise indicated. Triglycerides, HbA1c, creatinine, and albumin-to-creatinine ratio were tested after transforming to approximate normality. The P value is for a test of equality between the regions after adjustment for age, sex, and duration of diabetes.

*Standardized by analyses on common standard samples (5). (All other results quoted in this article are unstandardized.)